Oculis’ (OCS) Buy Rating Reiterated at Chardan Capital
Chardan Capital reissued their buy rating on shares of Oculis (NASDAQ:OCS – Free Report) in a research report released on Thursday,Benzinga reports. They currently have a $28.00 target price on the stock. Several other research analysts have also commented on OCS. Robert W. Baird raised their price objective on shares of Oculis from $37.00 to […]
